Document is current
Any future updates will be listed below
-
Authors
de Villiers, Laing
Swartz, Leslie
Bock, Peter
Seeley, Janet
Stangl, Anne L.
Bond, Virginia
Hargreaves, James
Hoddinott, Graeme
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-006920)
- License Information
-
More Information
Article History
Received: 17 January 2023
Accepted: 20 June 2024
First Online: 6 July 2024
Declarations
:
: The HPTN 071 (PopART) trial [Division of AIDS (DAIDS) number 11865 and Clinical Trials registration number NCT01900977 (17/07/2013)] and the stigma ancillary study (DAIDS number HPTN071a) received Institutional Review Board approval from the London School of Hygiene and Tropical Medicine, LSHTM, the Health Research Ethics Committee, Stellenbosch University, and the Biomedical Research Ethics Committee at the University of Zambia. The HPTN 071 (PopART) trial received ethical clearance from the London School of Hygiene and Tropical Medicine and the Stellenbosch University research ethics committee (N12/09/056; N12/11/074). Accordingly, all participants who were recruited for this study were consented initially, whether they continued throughout the study or not. All members of a household who were part of one or more in-depth discussions signed written informed consent, informed consent has been obtained from all the participants and their parents/legal guardians. All data presented use fictional pseudonyms. All methods were carried out in accordance with relevant guidelines and regulations. All members of a household who were part of one or more in-depth discussions signed written informed consent, informed consent has been obtained from all the participants and their parents/legal guardians.
: Not Applicable.
: The authors declare no competing interests.
